nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF2—malignant glioma	0.72	1	CbGaD
Pentosan Polysulfate—FGF4—embryo—malignant glioma	0.0112	0.217	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—malignant glioma	0.00539	0.104	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—malignant glioma	0.00497	0.0959	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—malignant glioma	0.00296	0.0572	CbGeAlD
Pentosan Polysulfate—FGF1—brainstem—malignant glioma	0.00272	0.0524	CbGeAlD
Pentosan Polysulfate—FGF1—retina—malignant glioma	0.00262	0.0506	CbGeAlD
Pentosan Polysulfate—FGF2—medulla oblongata—malignant glioma	0.00255	0.0492	CbGeAlD
Pentosan Polysulfate—Retinal haemorrhage—Carmustine—malignant glioma	0.00252	0.0879	CcSEcCtD
Pentosan Polysulfate—FGF1—telencephalon—malignant glioma	0.00241	0.0465	CbGeAlD
Pentosan Polysulfate—FGF2—midbrain—malignant glioma	0.00233	0.0449	CbGeAlD
Pentosan Polysulfate—FGF2—spinal cord—malignant glioma	0.00227	0.0438	CbGeAlD
Pentosan Polysulfate—FGF1—medulla oblongata—malignant glioma	0.00189	0.0366	CbGeAlD
Pentosan Polysulfate—FGF2—cerebellum—malignant glioma	0.0018	0.0348	CbGeAlD
Pentosan Polysulfate—FGF1—midbrain—malignant glioma	0.00173	0.0334	CbGeAlD
Pentosan Polysulfate—FGF1—spinal cord—malignant glioma	0.00169	0.0326	CbGeAlD
Pentosan Polysulfate—FGF2—brain—malignant glioma	0.00146	0.0282	CbGeAlD
Pentosan Polysulfate—FGF1—central nervous system—malignant glioma	0.00137	0.0265	CbGeAlD
Pentosan Polysulfate—FGF1—cerebellum—malignant glioma	0.00134	0.0259	CbGeAlD
Pentosan Polysulfate—FGF1—brain—malignant glioma	0.00109	0.021	CbGeAlD
Pentosan Polysulfate—Menorrhagia—Temozolomide—malignant glioma	0.00107	0.0374	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Temozolomide—malignant glioma	0.000905	0.0315	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Temozolomide—malignant glioma	0.000795	0.0277	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Temozolomide—malignant glioma	0.00075	0.0261	CcSEcCtD
Pentosan Polysulfate—Affect lability—Temozolomide—malignant glioma	0.000568	0.0198	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Carmustine—malignant glioma	0.000551	0.0192	CcSEcCtD
Pentosan Polysulfate—Mood swings—Temozolomide—malignant glioma	0.000547	0.019	CcSEcCtD
Pentosan Polysulfate—Dehydration—Temozolomide—malignant glioma	0.000537	0.0187	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Temozolomide—malignant glioma	0.000486	0.0169	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Temozolomide—malignant glioma	0.000461	0.0161	CcSEcCtD
Pentosan Polysulfate—Depression—Carmustine—malignant glioma	0.000459	0.016	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Temozolomide—malignant glioma	0.000455	0.0159	CcSEcCtD
Pentosan Polysulfate—Weight increased—Temozolomide—malignant glioma	0.000454	0.0158	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Temozolomide—malignant glioma	0.000451	0.0157	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Carmustine—malignant glioma	0.000448	0.0156	CcSEcCtD
Pentosan Polysulfate—Depression—Temozolomide—malignant glioma	0.000443	0.0154	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Temozolomide—malignant glioma	0.000433	0.0151	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Temozolomide—malignant glioma	0.000417	0.0145	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Temozolomide—malignant glioma	0.000396	0.0138	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Temozolomide—malignant glioma	0.000372	0.013	CcSEcCtD
Pentosan Polysulfate—Alopecia—Carmustine—malignant glioma	0.000365	0.0127	CcSEcCtD
Pentosan Polysulfate—Alopecia—Temozolomide—malignant glioma	0.000353	0.0123	CcSEcCtD
Pentosan Polysulfate—Anaemia—Carmustine—malignant glioma	0.000332	0.0116	CcSEcCtD
Pentosan Polysulfate—Agitation—Carmustine—malignant glioma	0.00033	0.0115	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Temozolomide—malignant glioma	0.000322	0.0112	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Carmustine—malignant glioma	0.000322	0.0112	CcSEcCtD
Pentosan Polysulfate—Anaemia—Temozolomide—malignant glioma	0.000321	0.0112	CcSEcCtD
Pentosan Polysulfate—Agitation—Temozolomide—malignant glioma	0.000319	0.0111	CcSEcCtD
Pentosan Polysulfate—Malaise—Temozolomide—malignant glioma	0.000313	0.0109	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Temozolomide—malignant glioma	0.000311	0.0108	CcSEcCtD
Pentosan Polysulfate—Myalgia—Carmustine—malignant glioma	0.000306	0.0107	CcSEcCtD
Pentosan Polysulfate—Myalgia—Temozolomide—malignant glioma	0.000296	0.0103	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Temozolomide—malignant glioma	0.000296	0.0103	CcSEcCtD
Pentosan Polysulfate—Oedema—Carmustine—malignant glioma	0.000293	0.0102	CcSEcCtD
Pentosan Polysulfate—Discomfort—Temozolomide—malignant glioma	0.000292	0.0102	CcSEcCtD
Pentosan Polysulfate—Infection—Carmustine—malignant glioma	0.000292	0.0102	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Carmustine—malignant glioma	0.000287	0.01	CcSEcCtD
Pentosan Polysulfate—Oedema—Temozolomide—malignant glioma	0.000284	0.00988	CcSEcCtD
Pentosan Polysulfate—Infection—Temozolomide—malignant glioma	0.000282	0.00982	CcSEcCtD
Pentosan Polysulfate—Anorexia—Carmustine—malignant glioma	0.00028	0.00975	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Temozolomide—malignant glioma	0.000278	0.00967	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Temozolomide—malignant glioma	0.000274	0.00955	CcSEcCtD
Pentosan Polysulfate—Anorexia—Temozolomide—malignant glioma	0.00027	0.00942	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000267	0.00932	CcSEcCtD
Pentosan Polysulfate—Insomnia—Carmustine—malignant glioma	0.000265	0.00925	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Carmustine—malignant glioma	0.000263	0.00918	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Carmustine—malignant glioma	0.000262	0.00912	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000258	0.009	CcSEcCtD
Pentosan Polysulfate—Insomnia—Temozolomide—malignant glioma	0.000256	0.00894	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Carmustine—malignant glioma	0.000255	0.00889	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Temozolomide—malignant glioma	0.000255	0.00887	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Temozolomide—malignant glioma	0.000253	0.00881	CcSEcCtD
Pentosan Polysulfate—Constipation—Carmustine—malignant glioma	0.000251	0.00874	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Temozolomide—malignant glioma	0.00025	0.0087	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Temozolomide—malignant glioma	0.000247	0.00859	CcSEcCtD
Pentosan Polysulfate—Constipation—Temozolomide—malignant glioma	0.000242	0.00845	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Carmustine—malignant glioma	0.000242	0.00843	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Carmustine—malignant glioma	0.00024	0.00836	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Temozolomide—malignant glioma	0.000234	0.00814	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Carmustine—malignant glioma	0.000232	0.00808	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Temozolomide—malignant glioma	0.000232	0.00808	CcSEcCtD
Pentosan Polysulfate—Urticaria—Temozolomide—malignant glioma	0.000225	0.00785	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Temozolomide—malignant glioma	0.000224	0.00781	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Carmustine—malignant glioma	0.000216	0.00753	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Temozolomide—malignant glioma	0.000209	0.00728	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Carmustine—malignant glioma	0.000201	0.007	CcSEcCtD
Pentosan Polysulfate—Pruritus—Temozolomide—malignant glioma	0.000201	0.00699	CcSEcCtD
Pentosan Polysulfate—Dizziness—Carmustine—malignant glioma	0.000194	0.00676	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Temozolomide—malignant glioma	0.000194	0.00676	CcSEcCtD
Pentosan Polysulfate—Dizziness—Temozolomide—malignant glioma	0.000188	0.00653	CcSEcCtD
Pentosan Polysulfate—Vomiting—Carmustine—malignant glioma	0.000187	0.0065	CcSEcCtD
Pentosan Polysulfate—Rash—Carmustine—malignant glioma	0.000185	0.00645	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Carmustine—malignant glioma	0.000185	0.00644	CcSEcCtD
Pentosan Polysulfate—Headache—Carmustine—malignant glioma	0.000184	0.00641	CcSEcCtD
Pentosan Polysulfate—Vomiting—Temozolomide—malignant glioma	0.00018	0.00628	CcSEcCtD
Pentosan Polysulfate—Rash—Temozolomide—malignant glioma	0.000179	0.00623	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Temozolomide—malignant glioma	0.000179	0.00622	CcSEcCtD
Pentosan Polysulfate—Headache—Temozolomide—malignant glioma	0.000178	0.00619	CcSEcCtD
Pentosan Polysulfate—Nausea—Carmustine—malignant glioma	0.000174	0.00607	CcSEcCtD
Pentosan Polysulfate—Nausea—Temozolomide—malignant glioma	0.000168	0.00587	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—FGFR1—malignant glioma	1.59e-05	7.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—STAT3—malignant glioma	1.59e-05	7.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—malignant glioma	1.59e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BDKRB2—malignant glioma	1.59e-05	7.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—malignant glioma	1.59e-05	7.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KNG1—malignant glioma	1.58e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—malignant glioma	1.58e-05	7.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOTCH1—malignant glioma	1.58e-05	7.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—malignant glioma	1.57e-05	7.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BAD—malignant glioma	1.56e-05	7.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—malignant glioma	1.56e-05	7.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CD80—malignant glioma	1.55e-05	7.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APC—malignant glioma	1.54e-05	7.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CG—malignant glioma	1.54e-05	7.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CAV1—malignant glioma	1.54e-05	7.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGF—malignant glioma	1.53e-05	7.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD80—malignant glioma	1.52e-05	7.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTPN11—malignant glioma	1.52e-05	7.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HLA-A—malignant glioma	1.51e-05	7.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—malignant glioma	1.51e-05	7.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NTRK1—malignant glioma	1.51e-05	7.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—malignant glioma	1.51e-05	7.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—malignant glioma	1.5e-05	7.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGF—malignant glioma	1.5e-05	7.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTPN11—malignant glioma	1.49e-05	7.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PDGFB—malignant glioma	1.48e-05	7.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH2—malignant glioma	1.48e-05	7.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FGFR1—malignant glioma	1.47e-05	7.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—malignant glioma	1.46e-05	7.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—malignant glioma	1.45e-05	7.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—malignant glioma	1.45e-05	7.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—malignant glioma	1.45e-05	7.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BAD—malignant glioma	1.44e-05	7.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KNG1—malignant glioma	1.44e-05	7.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOTCH1—malignant glioma	1.43e-05	7.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BAD—malignant glioma	1.43e-05	7.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STAT3—malignant glioma	1.41e-05	7.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT2—malignant glioma	1.41e-05	7.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP3—malignant glioma	1.4e-05	7.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CD80—malignant glioma	1.4e-05	7.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CAV1—malignant glioma	1.4e-05	7.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—malignant glioma	1.4e-05	7.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APC—malignant glioma	1.4e-05	7.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN2B—malignant glioma	1.39e-05	6.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT2—malignant glioma	1.39e-05	6.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD80—malignant glioma	1.38e-05	6.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGF—malignant glioma	1.38e-05	6.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—malignant glioma	1.38e-05	6.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NTRK1—malignant glioma	1.38e-05	6.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTPN11—malignant glioma	1.37e-05	6.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGF—malignant glioma	1.37e-05	6.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—malignant glioma	1.37e-05	6.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTPN11—malignant glioma	1.36e-05	6.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CD—malignant glioma	1.36e-05	6.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTK2—malignant glioma	1.35e-05	6.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—malignant glioma	1.34e-05	6.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CD—malignant glioma	1.33e-05	6.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HES1—malignant glioma	1.33e-05	6.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—malignant glioma	1.32e-05	6.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NCOR1—malignant glioma	1.32e-05	6.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BAD—malignant glioma	1.32e-05	6.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—malignant glioma	1.32e-05	6.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STAT3—malignant glioma	1.31e-05	6.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOTCH1—malignant glioma	1.3e-05	6.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FGF2—malignant glioma	1.3e-05	6.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—malignant glioma	1.28e-05	6.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT2—malignant glioma	1.28e-05	6.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP3—malignant glioma	1.28e-05	6.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CD80—malignant glioma	1.28e-05	6.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—malignant glioma	1.28e-05	6.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—malignant glioma	1.28e-05	6.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FGF2—malignant glioma	1.28e-05	6.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—malignant glioma	1.27e-05	6.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN2B—malignant glioma	1.27e-05	6.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT2—malignant glioma	1.26e-05	6.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFRA—malignant glioma	1.26e-05	6.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGF—malignant glioma	1.26e-05	6.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTPN11—malignant glioma	1.25e-05	6.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTK2—malignant glioma	1.23e-05	6.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—malignant glioma	1.23e-05	6.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SPP1—malignant glioma	1.23e-05	6.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—malignant glioma	1.23e-05	6.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—malignant glioma	1.22e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—malignant glioma	1.22e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—malignant glioma	1.21e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—malignant glioma	1.21e-05	6.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—malignant glioma	1.21e-05	6.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RAF1—malignant glioma	1.21e-05	6.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—BCL2—malignant glioma	1.21e-05	6.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HES1—malignant glioma	1.21e-05	6.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—malignant glioma	1.21e-05	6.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NCOR1—malignant glioma	1.2e-05	6.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNG—malignant glioma	1.2e-05	6.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—malignant glioma	1.2e-05	6.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—malignant glioma	1.2e-05	6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—malignant glioma	1.19e-05	5.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—RAF1—malignant glioma	1.19e-05	5.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—malignant glioma	1.19e-05	5.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—malignant glioma	1.18e-05	5.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FGF2—malignant glioma	1.18e-05	5.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—malignant glioma	1.18e-05	5.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT2—malignant glioma	1.17e-05	5.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—malignant glioma	1.17e-05	5.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—malignant glioma	1.16e-05	5.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—malignant glioma	1.16e-05	5.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—malignant glioma	1.16e-05	5.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRA—malignant glioma	1.15e-05	5.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—malignant glioma	1.14e-05	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFB—malignant glioma	1.14e-05	5.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGFR1—malignant glioma	1.13e-05	5.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—malignant glioma	1.12e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—malignant glioma	1.12e-05	5.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SPP1—malignant glioma	1.12e-05	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—malignant glioma	1.12e-05	5.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—malignant glioma	1.11e-05	5.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—malignant glioma	1.11e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—BCL2—malignant glioma	1.1e-05	5.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—malignant glioma	1.1e-05	5.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—RAF1—malignant glioma	1.1e-05	5.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—malignant glioma	1.09e-05	5.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—malignant glioma	1.09e-05	5.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—malignant glioma	1.09e-05	5.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—malignant glioma	1.09e-05	5.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—malignant glioma	1.09e-05	5.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—RAF1—malignant glioma	1.08e-05	5.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CAV1—malignant glioma	1.08e-05	5.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—malignant glioma	1.07e-05	5.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—malignant glioma	1.07e-05	5.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—malignant glioma	1.07e-05	5.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—malignant glioma	1.07e-05	5.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—malignant glioma	1.06e-05	5.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—malignant glioma	1.06e-05	5.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—malignant glioma	1.06e-05	5.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—malignant glioma	1.06e-05	5.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—malignant glioma	1.06e-05	5.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFB—malignant glioma	1.04e-05	5.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FGFR1—malignant glioma	1.03e-05	5.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—malignant glioma	1.03e-05	5.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—malignant glioma	1.03e-05	5.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—malignant glioma	1.03e-05	5.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—F2—malignant glioma	1.02e-05	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FN1—malignant glioma	1.02e-05	5.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—malignant glioma	1.02e-05	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—malignant glioma	1.01e-05	5.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BAD—malignant glioma	1.01e-05	5.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—malignant glioma	1e-05	5.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—malignant glioma	1e-05	5.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOTCH1—malignant glioma	1e-05	5.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—RAF1—malignant glioma	1e-05	5.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—malignant glioma	9.93e-06	4.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—malignant glioma	9.91e-06	4.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CD80—malignant glioma	9.82e-06	4.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CAV1—malignant glioma	9.81e-06	4.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—malignant glioma	9.8e-06	4.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—malignant glioma	9.8e-06	4.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—malignant glioma	9.78e-06	4.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—malignant glioma	9.76e-06	4.89e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—malignant glioma	9.73e-06	4.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—malignant glioma	9.7e-06	4.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—malignant glioma	9.69e-06	4.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGF—malignant glioma	9.69e-06	4.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTPN11—malignant glioma	9.63e-06	4.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—malignant glioma	9.53e-06	4.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—F2—malignant glioma	9.34e-06	4.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FN1—malignant glioma	9.34e-06	4.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—malignant glioma	9.26e-06	4.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—malignant glioma	9.23e-06	4.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BAD—malignant glioma	9.23e-06	4.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—malignant glioma	9.21e-06	4.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—malignant glioma	9.15e-06	4.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—malignant glioma	9.14e-06	4.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOTCH1—malignant glioma	9.14e-06	4.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—malignant glioma	9.11e-06	4.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—malignant glioma	9.05e-06	4.54e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—malignant glioma	8.97e-06	4.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT2—malignant glioma	8.96e-06	4.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CD80—malignant glioma	8.95e-06	4.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—malignant glioma	8.94e-06	4.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—malignant glioma	8.94e-06	4.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGF—malignant glioma	8.83e-06	4.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTPN11—malignant glioma	8.78e-06	4.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—malignant glioma	8.69e-06	4.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—malignant glioma	8.61e-06	4.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—malignant glioma	8.49e-06	4.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—malignant glioma	8.45e-06	4.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—malignant glioma	8.41e-06	4.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—malignant glioma	8.4e-06	4.21e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—malignant glioma	8.31e-06	4.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—malignant glioma	8.29e-06	4.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FGF2—malignant glioma	8.25e-06	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—malignant glioma	8.18e-06	4.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT2—malignant glioma	8.18e-06	4.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—malignant glioma	8.16e-06	4.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—malignant glioma	7.85e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—malignant glioma	7.85e-06	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—malignant glioma	7.72e-06	3.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—malignant glioma	7.71e-06	3.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—malignant glioma	7.7e-06	3.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RAF1—malignant glioma	7.69e-06	3.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—malignant glioma	7.61e-06	3.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—malignant glioma	7.56e-06	3.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—malignant glioma	7.53e-06	3.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—malignant glioma	7.51e-06	3.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—malignant glioma	7.44e-06	3.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—malignant glioma	7.21e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—malignant glioma	7.21e-06	3.61e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—malignant glioma	7.11e-06	3.56e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—malignant glioma	7.08e-06	3.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—malignant glioma	7.04e-06	3.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—malignant glioma	7.03e-06	3.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—malignant glioma	7.02e-06	3.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RAF1—malignant glioma	7.01e-06	3.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—malignant glioma	6.98e-06	3.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—malignant glioma	6.94e-06	3.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—malignant glioma	6.91e-06	3.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—malignant glioma	6.9e-06	3.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—malignant glioma	6.87e-06	3.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—malignant glioma	6.85e-06	3.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—malignant glioma	6.58e-06	3.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—malignant glioma	6.54e-06	3.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—malignant glioma	6.53e-06	3.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—malignant glioma	6.49e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—malignant glioma	6.49e-06	3.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—malignant glioma	6.46e-06	3.23e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—malignant glioma	6.3e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—malignant glioma	6.29e-06	3.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—malignant glioma	5.96e-06	2.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—malignant glioma	5.95e-06	2.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—malignant glioma	5.92e-06	2.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—malignant glioma	5.89e-06	2.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—malignant glioma	5.86e-06	2.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—malignant glioma	5.8e-06	2.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—malignant glioma	5.78e-06	2.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—malignant glioma	5.39e-06	2.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—malignant glioma	5.34e-06	2.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—malignant glioma	5.34e-06	2.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—malignant glioma	5.29e-06	2.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—malignant glioma	5.27e-06	2.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—malignant glioma	5.27e-06	2.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—malignant glioma	4.98e-06	2.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—malignant glioma	4.92e-06	2.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—malignant glioma	4.87e-06	2.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—malignant glioma	4.81e-06	2.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—malignant glioma	4.58e-06	2.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—malignant glioma	4.54e-06	2.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—malignant glioma	4.43e-06	2.22e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—malignant glioma	4.17e-06	2.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—malignant glioma	4.04e-06	2.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—malignant glioma	3.74e-06	1.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—malignant glioma	3.41e-06	1.71e-05	CbGpPWpGaD
